Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-25

FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)

View source ↗

Summary

FDA approved a supplemental application for SALONPAS PAIN RELIEF (menthol, methyl salicylate) from Hisamitsu Pharmaceutical Co., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SALONPAS PAIN RELIEF (MENTHOL, METHYL SALICYLATE)

Snippet

SUPPL AP for SALONPAS PAIN RELIEF (MENTHOL, METHYL SALICYLATE)